NCT02318550

Brief Summary

The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
262

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

December 10, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 17, 2014

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

May 17, 2021

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

3.6 years

First QC Date

December 10, 2014

Results QC Date

April 22, 2021

Last Update Submit

August 30, 2021

Conditions

Outcome Measures

Primary Outcomes (10)

  • Number of Participants With Burning or Pulling Sensations in Chest/Device Pocket During MRI

    Through procedure completion, an average of 1 hour

  • Number of Participants With Potentially Lethal/Previously Non-diagnosed Arrhythmias During MRI

    Through procedure completion, an average of 1 hour

  • Number of Participants With Spontaneous and Unanticipated Pacing Rate Change

    Through procedure completion, an average of 1 hour

  • Number of Participants With Power on Reset of Pacemaker or ICD

    Through procedure completion, an average of 1 hour

  • Number of Participants With MRI Related Device Malfunction/Failure

    Through procedure completion, an average of 1 hour

  • Number of Participants With Serious Injury/Death Related to MRI Device Malfunction/Failure

    Through procedure completion, an average of 1 hour

  • Number of MRI Scans With Post-MRI Device Parameter Change: Greater Than 50 Ohm Change in Atrial or Ventricular (RV and/or LV) Lead Impedance

    Through procedure completion, an average of 1 hour

  • Number of MRI Scans With Post-MRI Device Parameter Changes: Greater Than 5 Ohm Change in High Voltage Lead Impedance

    Through procedure completion, an average of 1 hour

  • Number of MRI Scans With Post-MRI Device Parameter Changes: Greater Than 50% Decrease in Atrial or Ventricular (RV and/or LV) Sensing Threshold

    Through procedure completion, an average of 1 hour

  • Number of MRI Scans With Post-MRI Device Parameter Changes: Greater Than or Equal to a 1 Volt Increase in Atrial or Ventricular (RV and/or LV) Pacing Threshold

    Through procedure completion, an average of 1 hour

Interventions

The MRI will be performed with a 1.5 T scanner utilizing institutional protocols and the following settings: * Normal operating mode * SAR ≤ 2.0 W/kg per patient.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient with any commercially available pacemaker or ICD system implanted after 2001 who meet all of the inclusion criteria and none of the exclusion criteria, and who require a non-cardiac, medically-indicated MRI as described above will be eligible to enroll in the study.

You may not qualify if:

  • Non-device related contraindication for MRI (such as implanted metallic objects, claustrophobia, morbid obesity)
  • Presence of capped/abandoned/epicardial leads or subcutaneous coil
  • Pregnancy
  • Device generator at elective replacement interval
  • Abdominal device implant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lancaster General Hospital

Lancaster, Pennsylvania, 17604, United States

Location

Related Publications (5)

  • Mollerus M, Albin G, Lipinski M, Lucca J. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol. 2009 Jun;32(6):772-8. doi: 10.1111/j.1540-8159.2009.02364.x.

    PMID: 19545340BACKGROUND
  • Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.

    PMID: 21969340BACKGROUND
  • Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006 Sep 19;114(12):1277-84. doi: 10.1161/CIRCULATIONAHA.105.607655. Epub 2006 Sep 11.

    PMID: 16966586BACKGROUND
  • Nazarian S, Beinart R, Halperin HR. Magnetic resonance imaging and implantable devices. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):419-28. doi: 10.1161/CIRCEP.113.000116. No abstract available.

    PMID: 23592868BACKGROUND
  • Ferreira AM, Costa F, Tralhao A, Marques H, Cardim N, Adragao P. MRI-conditional pacemakers: current perspectives. Med Devices (Auckl). 2014 May 7;7:115-24. doi: 10.2147/MDER.S44063. eCollection 2014.

    PMID: 24851058BACKGROUND

Related Links

MeSH Terms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Results Point of Contact

Title
Project Manager
Organization
Lancaster General Health

Study Officials

  • Sandeep Bansal, MD

    Lancaster General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2014

First Posted

December 17, 2014

Study Start

December 1, 2014

Primary Completion

June 30, 2018

Study Completion

June 30, 2018

Last Updated

August 31, 2021

Results First Posted

May 17, 2021

Record last verified: 2021-08

Locations